TapewireFind a company

person · Reporting owner

BERGER DAVID B

Disclosed activity across 1 company

Tapewire entity
107893
SEC CIK
0001422126

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
TANDEM DIABETES CARE INCTNDM · Entity 4682EVP & Chief Operating OfficerNovember 27, 2023November 29, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

TANDEM DIABETES CARE INC

Report date November 27, 2023 · Filed November 29, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect6,338 Ending reported balance After 2023-11-27 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2023-11-27 · Exercise / conversion · Acquired 406 · Balance 6,479

Row 2 · 2023-11-27 · Tax withholding · Disposed 141 · Balance 6,338

F1: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect813 Reported balance After 2023-11-27 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2023-11-27 · Exercise / conversion · Disposed 406 · Balance 813

F3: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Common StockSEC Table I · non-derivativeIndirectBerger Family Trust242 Reported balance Holding disclosure · report date 2023-11-27 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 242

F2: The securities are held by the Berger Family Trust dated April 16, 2008.

Filing footnotes · ownership attribution and instrument terms

F1: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

F2: The securities are held by the Berger Family Trust dated April 16, 2008.

F3: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 29, 2022 Filed Aug 31, 2022 20:41 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 407 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000199 · wf-form4_166197845553750.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,845

Underlying: Common Stock · 407 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
August 29, 2022 Filed Aug 31, 2022 20:41 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 202 $46.68 $9,429.36
Disclosure

SEC source: 0001438133-22-000199 · wf-form4_166197845553750.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,743

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 29, 2022 Filed Aug 31, 2022 20:41 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 407 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000199 · wf-form4_166197845553750.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,945

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 20:57 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000185 · wf-form4_166076982986993.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,787

Underlying: Common Stock · 162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 20:57 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 81 $55.25 $4,475.25
Disclosure

SEC source: 0001438133-22-000185 · wf-form4_166076982986993.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,538

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 20:57 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000185 · wf-form4_166076982986993.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,619

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 08, 2022 Filed Jun 10, 2022 20:57 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 7,000 $18.86 Strike: $18.86 $132,020.00
Disclosure

SEC source: 0001438133-22-000159 · wf-form4_165489466446731.xml · derivative · entry 5

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 7,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options granted on 6/14/2018 vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan ("the 2013 Plan").

F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
June 08, 2022 Filed Jun 10, 2022 20:57 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 3,097 $65.00 $201,305.00
Disclosure

SEC source: 0001438133-22-000159 · wf-form4_165489466446731.xml · nonDerivative · entry 3

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,457

Read SEC document
June 08, 2022 Filed Jun 10, 2022 20:57 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 7,000 $65.03 $455,210.00
Disclosure

SEC source: 0001438133-22-000159 · wf-form4_165489466446731.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,554

F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $65.00 to $65.10. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
June 08, 2022 Filed Jun 10, 2022 20:57 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 7,000 $18.86 $132,020.00
Disclosure

SEC source: 0001438133-22-000159 · wf-form4_165489466446731.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,554

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2022 Filed Jun 2, 2022 00:15 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000143 · wf-form4_165412888804851.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,252

Underlying: Common Stock · 406 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan ("the 2013 Plan").

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F5 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
May 27, 2022 Filed Jun 2, 2022 00:15 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 202 $70.81 $14,303.62
Disclosure

SEC source: 0001438133-22-000143 · wf-form4_165412888804851.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,554

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 27, 2022 Filed Jun 2, 2022 00:15 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000143 · wf-form4_165412888804851.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,756

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 25, 2022 Filed May 28, 2022 01:49 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantStock Option · Derivative 8,544 $0.00 Strike: $65.28 $0.00
Disclosure

SEC source: 0001438133-22-000128 · wf-form4_165370252215867.xml · derivative · entry 5

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,544

Underlying: Common Stock · 8,544 shares

Expires not disclosed

F2 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F6 · derivative.exercise_date: The option shall vest as to thirty-three percent (33%) of the underlying shares on the one-year anniversary of the grant date, and the remaining shares shall vest in twenty-four (24) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
May 25, 2022 Filed May 28, 2022 01:49 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantPerformance Stock Unit · Derivative 5,523 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000128 · wf-form4_165370252215867.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,523

Underlying: Common Stock · 5,523 shares

Expires not disclosed

F2 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F5 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

F5 · derivative.exercise_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

F5 · derivative.expiration_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

Read SEC document
May 25, 2022 Filed May 28, 2022 01:49 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantRestricted Stock Unit · Derivative 5,691 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000128 · wf-form4_165370252215867.xml · derivative · entry 3

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,691

Underlying: Common Stock · 5,691 shares

Expires not disclosed

F2 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the2013 Plan.

F4 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 16, 2022 Filed May 18, 2022 23:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 650 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000079 · wf-form4_165291533790049.xml · derivative · entry 5

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,949

Underlying: Common Stock · 650 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company.

F6 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F6 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
May 16, 2022 Filed May 18, 2022 23:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantCommon Stock 306 $61.17 $18,718.02
Disclosure

SEC source: 0001438133-22-000079 · wf-form4_165291533790049.xml · nonDerivative · entry 3

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,350

F2 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2021 through May 16, 2022. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
May 16, 2022 Filed May 18, 2022 23:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 323 $73.85 $23,853.55
Disclosure

SEC source: 0001438133-22-000079 · wf-form4_165291533790049.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,044

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 16, 2022 Filed May 18, 2022 23:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 650 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000079 · wf-form4_165291533790049.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,367

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 20:42 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 1,000 $18.86 Strike: $18.86 $18,860.00
Disclosure

SEC source: 0001438133-22-000046 · wf-form4_164919133994445.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,000

Underlying: Common Stock · 1,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 20:42 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 1,000 $117.88 $117,879.80
Disclosure

SEC source: 0001438133-22-000046 · wf-form4_164919133994445.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,717

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021.

F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $117.77 to $118.39. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 20:42 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 1,000 $18.86 $18,860.00
Disclosure

SEC source: 0001438133-22-000046 · wf-form4_164919133994445.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,717

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
March 16, 2022 Filed Mar 21, 2022 22:26 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 5,000 $18.86 Strike: $18.86 $94,300.00
Disclosure

SEC source: 0001438133-22-000041 · wf-form4_164790157987932.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,000

Underlying: Common Stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
March 16, 2022 Filed Mar 21, 2022 22:26 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 5,000 $108.37 $541,843.00
Disclosure

SEC source: 0001438133-22-000041 · wf-form4_164790157987932.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,717

F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $108.23 to $108.76. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
March 16, 2022 Filed Mar 21, 2022 22:26 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 5,000 $18.86 $94,300.00
Disclosure

SEC source: 0001438133-22-000041 · wf-form4_164790157987932.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,717

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 00:32 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 1,000 $18.86 Strike: $18.86 $18,860.00
Disclosure

SEC source: 0001438133-22-000035 · wf-form4_164626752716756.xml · derivative · entry 7

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,000

Underlying: Common Stock · 1,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F9 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 00:32 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 1,000 $112.68 $112,680.00
Disclosure

SEC source: 0001438133-22-000035 · wf-form4_164626752716756.xml · nonDerivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,717

F3 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 00:32 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 1,000 $18.86 $18,860.00
Disclosure

SEC source: 0001438133-22-000035 · wf-form4_164626752716756.xml · nonDerivative · entry 3

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,717

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 00:32 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 407 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000035 · wf-form4_164626752716756.xml · derivative · entry 6

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,658

Underlying: Common Stock · 407 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company.

F7 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F7 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 00:32 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 141 $112.43 $15,852.63
Disclosure

SEC source: 0001438133-22-000035 · wf-form4_164626752716756.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,717

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 28, 2022 Filed Mar 3, 2022 00:32 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 407 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000035 · wf-form4_164626752716756.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,858

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 21:23 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 1,000 $18.86 Strike: $18.86 $18,860.00
Disclosure

SEC source: 0001438133-22-000008 · wf-form4_164392338173286.xml · derivative · entry 6

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,000

Underlying: Common Stock · 1,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F8 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 21:23 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 358 $118.89 $42,562.62
Disclosure

SEC source: 0001438133-22-000008 · wf-form4_164392338173286.xml · nonDerivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,451

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021.

F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $118.52 to $119.04. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 21:23 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 400 $117.78 $47,112.00
Disclosure

SEC source: 0001438133-22-000008 · wf-form4_164392338173286.xml · nonDerivative · entry 3

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,809

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021.

F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $117.46 to $118.12. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 21:23 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 242 $116.67 $28,234.14
Disclosure

SEC source: 0001438133-22-000008 · wf-form4_164392338173286.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,209

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021.

F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $116.36 to $116.99. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 21:23 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 1,000 $18.86 $18,860.00
Disclosure

SEC source: 0001438133-22-000008 · wf-form4_164392338173286.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,451

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:12 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 1,000 $18.86 Strike: $18.86 $18,860.00
Disclosure

SEC source: 0001438133-22-000002 · wf-form4_164142796642696.xml · derivative · entry 5

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 1,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:12 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 170 $150.40 $25,568.00
Disclosure

SEC source: 0001438133-22-000002 · wf-form4_164142796642696.xml · nonDerivative · entry 3

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,451

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021.

F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $150.31 to $150.52. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:12 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 830 $148.91 $123,595.30
Disclosure

SEC source: 0001438133-22-000002 · wf-form4_164142796642696.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,621

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021.

F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $148.78 to $149.26. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:12 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 1,000 $18.86 $18,860.00
Disclosure

SEC source: 0001438133-22-000002 · wf-form4_164142796642696.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,451

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 22:35 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 12,000 $18.86 Strike: $18.86 $226,320.00
Disclosure

SEC source: 0001438133-21-000230 · wf-form4_163978050072248.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,000

Underlying: Common Stock · 12,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 22:35 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 12,000 $144.25 $1,731,000.00
Disclosure

SEC source: 0001438133-21-000230 · wf-form4_163978050072248.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,451

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 22:35 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 12,000 $18.86 $226,320.00
Disclosure

SEC source: 0001438133-21-000230 · wf-form4_163978050072248.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,451

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 00:31 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 1,000 $18.86 Strike: $18.86 $18,860.00
Disclosure

SEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · derivative · entry 8

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,000

Underlying: Common Stock · 1,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F10 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 00:31 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 100 $129.61 $12,961.00
Disclosure

SEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · nonDerivative · entry 5

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,451

F3 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 00:31 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 900 $128.31 $115,479.00
Disclosure

SEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · nonDerivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,551

F3 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021.

F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $127.97 to $128.75. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
December 01, 2021 Filed Dec 2, 2021 00:31 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 1,000 $18.86 $18,860.00
Disclosure

SEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · nonDerivative · entry 3

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,451

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
November 29, 2021 Filed Dec 2, 2021 00:31 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · derivative · entry 7

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,065

Underlying: Common Stock · 406 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company.

F8 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F8 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
November 29, 2021 Filed Dec 2, 2021 00:31 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 202 $129.66 $26,191.32
Disclosure

SEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,451

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.